Doctor profile · Federal record
Dr. Walid El Ayass, M.D
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Salisbury, MD
- NPI 1700078250
- Accepts Medicare
- MIPS 79.5 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E Carroll Street
Salisbury, MD 218015422
(410) 749-1282
fax (410) 749-7821
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- April 24, 2014
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D73895
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700078250. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,170
Distinct HCPCS
10
Medicare allowed
$598,426
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2357 |
Injection, omalizumab, 5 mg | 4,815 | 20 | $38 | |
J2182 |
Injection, mepolizumab, 1 mg | 4,700 | 13 | $29 | |
J0897 |
Injection, denosumab, 1 mg | 4,020 | 19 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 266 | 131 | $126 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 262 | 61 | $79 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 198 | 151 | $84 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 189 | 92 | $101 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 142 | 46 | $149 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 122 | 45 | $172 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 76 | 33 | $134 |
In context: peer comparison
Among 3 peers in Salisbury Hematology & Oncology Physician, average services per provider: 460. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$46,643
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 35 | $30,341.70 | |
| AstraZeneca Pharmaceuticals Lp | 15 | $13,005.91 | |
| Novartis Pharmaceuticals Corporation | 4 | $2,000.28 | |
| Janssen Biotech, INC. | 3 | $200.49 | |
| Daiichi Sankyo INC. | 9 | $198.01 | |
| Eisai INC. | 3 | $154.46 | |
| GlaxoSmithKline, LLC. | 5 | $133.79 | |
| BeiGene USA, INC. | 1 | $120.83 | |
| Puma Biotechnology, INC. | 1 | $111.35 | |
| Pfizer INC. | 3 | $83.81 | |
| Gilead Sciences, INC. | 3 | $73.74 | |
| Genentech USA, INC. | 2 | $50.38 | |
| Regeneron Healthcare Solutions, INC. | 1 | $38.39 | |
| Alexion Pharmaceuticals, INC. | 1 | $30.65 | |
| Astellas Pharma US INC | 1 | $29.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
782
Patients
239
Total drug cost
$34,943
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 389 | 105 | $8,118 |
| Tamoxifen Citrate | Generic | 153 | 45 | $4,331 |
| Anastrozole | Generic | 43 | 18 | $1,561 |
| Potassium Chloride | Generic | 39 | 11 | $556 |
| Exemestane | Generic | 37 | 16 | $13,661 |
| Enoxaparin Sodium | Generic | 25 | 0 | $5,474 |
| Gabapentin | Generic | 24 | 0 | $79 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 23 | 15 | $410 |
| Prochlorperazine Maleate | Generic | 21 | 16 | $397 |
| Ondansetron Hcl | Generic | 17 | 13 | $228 |
Frequently asked questions
What is Dr. Walid El Ayass's medical specialty?
Dr. Walid El Ayass practices Hematology & Oncology Physician in Salisbury, MD.
Where does Dr. Walid El Ayass practice?
Dr. Walid El Ayass practices at 100 E Carroll Street, Salisbury, MD 218015422. Office phone: 4107491282.
What is Dr. Walid El Ayass's NPI?
Dr. Walid El Ayass's National Provider Identifier (NPI) is 1700078250, issued by NPPES.
Does Dr. Walid El Ayass accept Medicare assignment?
Yes. Dr. Walid El Ayass accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Walid El Ayass commonly perform?
Top Medicare-reported procedures in 2023: Injection, omalizumab, 5 mg (HCPCS J2357); Injection, mepolizumab, 1 mg (HCPCS J2182); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.